US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 14.790
  • +0.490+3.43%
Close Nov 25 16:00 ET
  • 14.837
  • +0.047+0.32%
Post 20:01 ET
1.51BMarket Cap-2713P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+2.10%
ARK Portfolio
ARK Portfolio
Intraday-2.09%